Literature DB >> 11205139

Homocysteine and alcoholism.

S Bleich1, D Degner, K Javaheripour, C Kurth, J Kornhuber.   

Abstract

Chronic alcohol consumption can induce alterations in the function and morphology of most if not all brain systems and structures. However, the exact mechanism of brain damage in alcoholics remains unknown. Partial recovery of brain function with abstinence suggests that a proportion of the deficits must be functional in origin (i.e. plastic changes of nerve cells) while neuronal loss from selected brain regions indicates permanent and irreversible damage. There is growing evidence that chronic alcoholism is associated with a derangement in the sulfur amino acid metabolism. Recently, it has been shown that excitatory amino acid (EAA) neurotransmitters and homocysteine levels are elevated in patients who underwent withdrawal from alcohol. Furthermore, it has been found that homocysteine induces neuronal cell damage by stimulating NMDA receptors as well as by producing free radicals. Homocysteine neurotoxicity via overstimulation of N-methyl-D-aspartate receptors may contribute to the pathogenesis of both brain shrinkage and withdrawal seizures linked to alcoholism.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11205139     DOI: 10.1007/978-3-7091-6301-6_12

Source DB:  PubMed          Journal:  J Neural Transm Suppl        ISSN: 0303-6995


  14 in total

1.  Are plasma homocysteine and methionine elevated when binging and purging behavior complicates anorexia nervosa? Evidence against the transdiagnostic theory of eating disorders.

Authors:  S M Innis; C L Birmingham; E J Harbottle
Journal:  Eat Weight Disord       Date:  2009-12       Impact factor: 4.652

2.  Methylenetetrahydrofolate reductase (MTHFR) C677T gene polymorphism and alcohol consumption in hyperhomocysteinaemia: a population-based study from northeast India.

Authors:  Huidrom Suraj Singh; Salam Kabita Devi; Kallur Nava Saraswathy
Journal:  J Genet       Date:  2015-03       Impact factor: 1.166

3.  Elevation of homocysteine levels is only partially reversed after therapy in females with eating disorders.

Authors:  Julia Wilhelm; Elisabeth Müller; Martina de Zwaan; Julia Fischer; Thomas Hillemacher; Johannes Kornhuber; Stefan Bleich; Helge Frieling
Journal:  J Neural Transm (Vienna)       Date:  2010-02-27       Impact factor: 3.575

Review 4.  [Folate against hyperhomocysteinemia. A new approach for the prevention and therapy of alcoholism-associated disorders?].

Authors:  S Bleich; K Löffelholz; J Kornhuber
Journal:  Nervenarzt       Date:  2004-05       Impact factor: 1.214

5.  Validation of differential GDAP1 DNA methylation in alcohol dependence and its potential function as a biomarker for disease severity and therapy outcome.

Authors:  Christof Brückmann; Adriana Di Santo; Kathrin Nora Karle; Anil Batra; Vanessa Nieratschker
Journal:  Epigenetics       Date:  2016-04-29       Impact factor: 4.528

6.  Association of hyperhomocysteinemia to alcohol withdrawal in chronic alcoholics.

Authors:  K Devika Rani; N Suneetha; Shruti Mohanty; Pragna Rao
Journal:  Indian J Clin Biochem       Date:  2008-06-11

7.  A Study on MTHFR C677T Gene Polymorphism and Alcohol Dependence among Meiteis of Manipur, India.

Authors:  Huidrom Suraj Singh; Kabita Salam; Kallur Nava Saraswathy
Journal:  J Biomark       Date:  2014-10-01

8.  Differential sensitivity of prefrontal cortex and hippocampus to alcohol-induced toxicity.

Authors:  Anna-Kate Fowler; Jeremy Thompson; Lixia Chen; Marisela Dagda; Janet Dertien; Katina Sylvestre S Dossou; Ruin Moaddel; Susan E Bergeson; Inna I Kruman
Journal:  PLoS One       Date:  2014-09-04       Impact factor: 3.240

9.  Homocysteine, cortisol, diabetes mellitus, and psychopathology.

Authors:  K Kontoangelos; C C Papageorgiou; A E Raptis; P Tsiotra; V Lambadiari; G N Papadimitriou; A D Rabavilas; G Dimitriadis; S A Raptis
Journal:  J Diabetes Res       Date:  2015-02-01       Impact factor: 4.011

10.  Alcohol related changes in regulation of NMDA receptor functions.

Authors:  József Nagy
Journal:  Curr Neuropharmacol       Date:  2008-03       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.